BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 29843676)

  • 21. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring predictors of medication adherence among inpatients with schizophrenia in Singapore's mental health settings: A non-experimental study.
    Tham XC; Xie H; Chng CML; Seah XY; Lopez V; Klainin-Yobas P
    Arch Psychiatr Nurs; 2018 Aug; 32(4):536-548. PubMed ID: 30029745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence therapy versus routine psychiatric care for people with schizophrenia spectrum disorders: a randomised controlled trial.
    Chien WT; Mui J; Gray R; Cheung E
    BMC Psychiatry; 2016 Feb; 16():42. PubMed ID: 26911397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset.
    Fond G; Boyer L; Boucekine M; Aden LA; Schürhoff F; Tessier A; Andrianarisoa M; Berna F; Brunel L; Capdevielle D; Chereau I; Mallet J; Denizot H; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Rey R; Richieri R; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Misdrahi D;
    Schizophr Res; 2017 Apr; 182():84-89. PubMed ID: 27789187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.
    McCann TV; Clark E; Lu S
    J Adv Nurs; 2009 Mar; 65(3):534-43. PubMed ID: 19222651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients: A Systematic Review.
    García S; Martínez-Cengotitabengoa M; López-Zurbano S; Zorrilla I; López P; Vieta E; González-Pinto A
    J Clin Psychopharmacol; 2016 Aug; 36(4):355-71. PubMed ID: 27307187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis.
    Semahegn A; Torpey K; Manu A; Assefa N; Tesfaye G; Ankomah A
    Syst Rev; 2020 Jan; 9(1):17. PubMed ID: 31948489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of medication adherence in patients with schizophrenia and bipolar disorder.
    Jónsdóttir H; Opjordsmoen S; Birkenaes AB; Simonsen C; Engh JA; Ringen PA; Vaskinn A; Friis S; Sundet K; Andreassen OA
    Acta Psychiatr Scand; 2013 Jan; 127(1):23-33. PubMed ID: 22900964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homeless women with schizophrenia reported lower adherence to their medication than men: results from the French Housing First experience.
    Tinland A; Zemmour K; Auquier P; Boucekine M; Girard V; Loubière S; Fond G; Boyer L;
    Soc Psychiatry Psychiatr Epidemiol; 2017 Sep; 52(9):1113-1122. PubMed ID: 28656452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Daily functioning and symptom factors contributing to attitudes toward antipsychotic treatment and treatment adherence in outpatients with schizophrenia spectrum disorders.
    Leijala J; Kampman O; Suvisaari J; Eskelinen S
    BMC Psychiatry; 2021 Jan; 21(1):37. PubMed ID: 33441112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective memory predicts medication management ability and correlates with non-adherence to medications in individuals with clinically stable schizophrenia.
    Lam JW; Lui SS; Wang Y; Chan RC; Cheung EF
    Schizophr Res; 2013 Jul; 147(2-3):293-300. PubMed ID: 23631929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schizophrenia medication adherence in a resource-poor setting: randomised controlled trial of supervised treatment in out-patients for schizophrenia (STOPS).
    Farooq S; Nazar Z; Irfan M; Akhter J; Gul E; Irfan U; Naeem F
    Br J Psychiatry; 2011 Dec; 199(6):467-72. PubMed ID: 22130748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attitudes to Medication-Treatment Among Patients and Caregivers: A Longitudinal Comparison of Bipolar Disorder and Schizophrenia From India.
    Chauhan N; Chakrabarti S; Grover S
    J Clin Psychopharmacol; 2020; 40(1):18-29. PubMed ID: 31804452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving Medication Adherence With Telemedicine for Adults With Severe Mental Illness.
    Schulze LN; Stentzel U; Leipert J; Schulte J; Langosch J; Freyberger HJ; Hoffmann W; Grabe HJ; van den Berg N
    Psychiatr Serv; 2019 Mar; 70(3):225-228. PubMed ID: 30651059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hand functions in patients with schizophrenia: A clinical comparison with bipolar disorder and healthy subjects.
    Yildirim MH; Yildirim EA; Carpar E; Coskun T; Ipekcioglu D; Canturk G
    Compr Psychiatry; 2018 Nov; 87():53-58. PubMed ID: 30199666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of side effects on schizophrenia and bipolar disorder patients' adherence to prescribed medical therapy.
    Ata EE; Bahadir-Yilmaz E; Bayrak NG
    Perspect Psychiatr Care; 2020 Jul; 56(3):691-696. PubMed ID: 32037576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical Antipsychotics for Schizophrenia and/or Bipolar Disorder in Pregnancy: Current Recommendations and Updates in the NICE Guidelines.
    Poo SX; Agius M
    Psychiatr Danub; 2015 Sep; 27 Suppl 1():S255-60. PubMed ID: 26417775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depressive residual symptoms are associated with lower adherence to medication in bipolar patients without substance use disorder: results from the FACE-BD cohort.
    Belzeaux R; Correard N; Boyer L; Etain B; Loftus J; Bellivier F; Bougerol T; Courtet P; Gard S; Kahn JP; Passerieux C; Leboyer M; Henry C; Azorin JM;
    J Affect Disord; 2013 Dec; 151(3):1009-15. PubMed ID: 24051101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.